Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1714/3660.36445 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Use of beta-blockaders in heart failure].
Tidsskr Nor Laegeforen
March 2003
Medisinsk avdeling Baerum sykehus 1306 Baerum postterminal.
[Intermittent claudication and beta blockaders. An unfortunate combination?].
Tidsskr Nor Laegeforen
March 1995
[Intermittent claudication and beta-blockaders. An unfortunate combination?].
Tidsskr Nor Laegeforen
February 1995
Medisinsk avdeling B, Rikshospitalet, Oslo.
beta-adrenergic blockers have been considered relatively contraindicated in patients with peripheral arterial disease because of reports claiming that these drugs may worsen intermittent claudication. The authors review the published randomized controlled trials and discuss the results of comparisons of this treatment with treatment with alternative drugs. None of the studies of beta-blockade in patients with intermittent claudication showed a reduction of walking distance or impairment of peripheral flow compared with patients given placebo, except one study using a beta-blocker with intrinsic sympathomimetic activity.
View Article and Find Full Text PDF[Treatment of hypertrophic cardiomyopathy with a combination of carnitine and beta blockaders. Review of the literature. Description of a clinical case and long-term follow up].
Clin Ter
August 1993
Sezione di Cardiologia e Unità Coronarica, USSL 44, Ospedale E. Agnelli Pinerolo, TO.
In the past decade, strategies for managing heart failure have changed. The use of beta blockers, although still in the experimental stage, has proved effective in some cases. The protective action of beta-blocking agents against chronic catecholamine stimulation may be enhanced by the combination with L-carnitine.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!